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Summary. Multi-drug resistant Klebsiella pneumoniae isolates are associated with nosocomial infections, in which colonized 
patients act as a reservoir and source of cross-infection for other patients. In this study, the antimicrobial susceptibility of K. 
pneumoniae was tested by microdilution using the commercial method MicroScan (Siemens). The genetic relatedness of K. 
pneumoniae strains was determined by pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). PCR 
experiments were carried out to obtain primer sets and positive PCR products were purified and sequenced. From May 2007 
until December 2009, 98 clonally related K. pneumoniae isolates were detected from clinical samples of 38 patients admitted 
to the University Hospital of Bellvitge, Barcelona, Spain, including 27 admitted to the intensive care unit (ICU). The most 
important sources of the isolates were: lower respiratory tract (n = 12), urine (n = 12), and blood (n = 11). The strains were 
resistant to amoxicillin/clavulanic acid, piperacillin/tazobactam, tobramycin, amikacin, and ciprofloxacin, and had diminished 
susceptibility to cefepime. All the isolates shared a common PFGE pattern related to sequence type 14 after MLST analysis. 
In K. pneumoniae isolates and their transconjugants, the blaOXA-1 gene was located in the variable region of a class I integron 
that also contains the aac(6′)Ib-cr gene. Sequencing of the quinolone resistance determinant regions of gyrA and parC revealed 
a S83F change in GyrA and no changes in ParC. [Int Microbiol 2013; 16(4):227-233]
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Introduction 
Klebsiella pneumoniae is a human pathogen that often colonizes 
the skin and mucosae of hospitalized patients, producing 
respiratory and urinary tract infections and bacteremia. Multi-
drug resistant isolates are associated with nosocomial infections, 
with colonized patients acting as a reservoir and source of 
cross-infection for other patients [3,16]. However, the genetic 
elements that encode resistance, especially betalactamases, are 
now spreading outside the hospital setting such that resistant 
isolates may also be recovered from patients with community-
acquired infections [6]. The virulence of K. pneumoniae 
strains is related to several bacterial factors, including the 
polysaccharidic capsule, lipopolysaccharide, iron scavenging 
systems, and fimbrial and non-fimbrial adhesins [6]. While 
isolates causing severe community-acquired infections are 
usually associated with a restricted number of K. pneumoniae 
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serotypes and clones, nosocomial isolates are highly diverse, 
suggesting that the bacterium is an opportunistic pathogen. 
Since the clonal complex is a good predictor of the virulence 
of K. pneumoniae isolates, the use of multilocus sequence 
typing (MLST) of the strains would improve investigations of 
nosocomial outbreaks [8].
Multidrug resistance patterns of K. pneumoniae and other 
enterobacteria are usually associated with the most frequently 
occurring integrons, those of class I, which carry different 
resistance determinants in the variable region and can be 
horizontally transferred intra- and inter-species [11,15]. The 
structure of class I integrons includes two conserved regions, 
5´CS and 3´CS, that flank the gene cassette. The 5´CS 
conserved segment contains a gene coding for an integrase 
(intI), a recombination site (attI), and a promoter of the 
gene cassette. The 3´CS conserved segment contains the 
qacEΔ1 and sulI genes, which confer resistance to quaternary 
ammonium compounds and sulfamethoxazole, respectively 
[11]. The variable region of the integrons is located between 
these two conserved segments and integrates the resistance 
genes. The variability of the gene cassettes causes the high 
diversity of antibiotic resistance [4,11]. Because of the easy 
bacterial acquisition of gene cassettes and their exchanges 
under different pressure conditions, many antibiotic resistance 
combinations are possible. The prolonged use of certain 
antibiotics also aids in the selection of certain resistance 
elements and promotes the persistence of multidrug-resistant 
(MDR) bacteria [4,11].
In our hospital, an active surveillance program against MDR 
K. pneumoniae started in 1993, after a nosocomial outbreak. 
Resistance was ascribed to extended-spectrum betalactamase 
(ESBL)-producing K. pneumoniae [16]. In May 2007, a possible 
new MDR strain of K. pneumoniae was isolated from a patient 
admitted to the intensive care unit (ICU). This strain spread in 
the following years, causing clustered infections throughout the 
hospital. Here we describe and characterize the K. pneumoniae 
isolates obtained during the subsequent surveillance program.
Materials and methods 
Study design and sampling. The present study was performed at the 
Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat (Barcelona), 
Spain,  a university teaching hospital for adults, with an average yearly admission 
of 26,000 patients. The hospital has three 12-bed medical-surgical ICUs. The 
surveillance of MDR K. pneumoniae began in May 2007, after the detection 
of several MDR non-ESBL K. pneumoniae isolates, and continued until 
December 2009. Clinical charts of patients were reviewed and assessment 
was determined using previously described methods [16]. Clinical samples 
collected within a month of each other from the same patient and that yielded 
isolates were considered as representative of different episodes. The isolation 
of K. pneumoniae from a patient without related signs or symptoms of infection 
was considered as a colonization. When K. pneumoniae was detected from a 
patient during an ICU stay or during the first week after ICU discharge, the 
infection was considered to be ICU-acquired. All other K. pneumoniae cases 
were considered as non-ICU-acquired. 
Antimicrobial susceptibility and molecular typing. 
Antimicrobial susceptibility was tested by microdilution using a commercial 
method MicroScan (Siemens). The multidrug resistance pattern was assessed 
by the disk diffusion method. The presence of an ESBL was screened by disk 
diffusion (Fig. 1) [1]. The genetic relatedness of K. pneumoniae strains was 
tested by pulsed field gel electrophoresis (PFGE). The entire DNA content was 
digested with XbaI. DNA-band analysis was performed by visual inspection 
following the criteria described by Tenover [18]. Strains differing in three or less 
bands were considered subtypes. Seven isolates were selected for multilocus 
sequence typing (MLST): two isolates with a common PFGE pattern (one 
isolated in August 2007 and the other in 2008) and one of each PFGE subtype 
pattern. MLST was performed following Protocol 2, which recommends 
universal sequencing primers, as described on the MLST web site of the Institut 
Pasteur [http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.
html]. The allele’s number and sequence type (ST) were assigned according to 
the recommendations of this web site.
Characterization of the multidrug resistance pattern. 
Isoelectric focusing of crude extracts was performed in accordance with 
previous procedures [1]. Strains of K. pneumoniae or their transconjugants 
were grown for 4 h in lysogeny broth (LB). The cells were then harvested by 
centrifugation, resuspended in distilled water, and sonicated. The resulting 
extracts were purified by ultracentrifugation. Isoelectric focusing was 
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Fig 1. Double disk synergy test of OXA-1-producing Klebsiella 
pneumoniae. AMP: ampicillin; TIC: ticarcillin; CFO: cefoxitin: NAL: 
nalidixic acid; AZT: aztreonam; CAZ: ceftazidime; CXM: cefuroxime; 
CIPR: ciprofloxacin; CTX: cefotaxime; AMC: amoxicillin/clavulanic 
acid; FO: fosfomycin; NI: nitrofurantoin; IMI: imipenem; FEP: 
cefepime; GEN: gentamicin; SXT: trimethoprim-sulfamethoxazole. 
There are synergy of FEP and CTX with AMC. 
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performed using the PhastSystem apparatus and polyacrylamide gels with 
a pH range of 3–9. The gels were then stained with 500 mg nitrocefin/ml, 
and the isoelectric points (pIs) were obtained by comparison with a set of 
different betalactamases of known pIs. 
Conjugation. These experiments were performed in LB using 
Escherichia coli J53-2 (rifampicin MIC ≥ 100 µg/ml) as recipient. 
Transconjugants were selected in trypticase soy agar plates containing 
both rifampicin (100 µg/ml) and tobramycin (16 µg /ml) and tested for 
antimicrobial susceptibility by disk diffusion and microdilution.
PCRs and characterization of integrons. A multiplex PCR 
assay, which includes detection of the TEM, SHV, OXA, CTX-M9 and 
CTX-M10 families of betalactamases, was used to characterize the 
betalactamase gene family members carried in K. pneumoniae strains 
and their transconjugants [9]. PCR experiments were repeated separately 
for primer sets that yielded a positive result and the PCR products were 
purified and sequenced (Table 1).
Characterization of ciprofloxacin resistance. Quinolone-
resistance-determining regions (QRDR) of GyrA and ParC were amplified 
and sequenced using the primers and conditions described previously 
[5]. A PCR assay was performed to detect the presence of the aac(6´)-
Ib-cr gene. The PCR products were sequenced to detect the quinolone-
modifying variant of this enzyme. The detection of class I integrons and the 
characterization of their variable region were carried out using previously 
described procedures (Table 1) [11].
Results and Discussion 
Description of the outbreak. During the study period 
(2007–2009), 366 K. pneumoniae strains were isolated from 
222 patients. Of these, 98 isolates obtained from the clinical 
samples of 38 patients shared a multidrug resistance pattern 
(see below). The mean age of the patients was 60.0 (SD ±18.4; 
range 19–85 years), and 23 patients (60.5 %) were men. Among 
the 38 patients studied, the infectious episodes in order of 
frequency were respiratory tract infection (bronchial aspirate, 7; 
bronchoalveolar lavage, 3; and tracheal aspirate, 1), bacteremia 
(9), and urinary tract infection (8). In the remaining ten patients, 
the isolates were collected from catheter-related samples (4), 
abdominal samples (3), wounds (2) and cerebrospinal fluid (1).
Klebsiella pneumoniae infection was acquired in the ICU 
in 27 patients. Figure 2 shows the temporal detection pattern in 
Table 1. Primers used in this study
Gene Primer Size PCR 
product
Ref.
blaSHV SHV fw
SHV rev
5′CTTTATCGGCCCTCACTCAA3′
5′AGGTGCTCATCATGGGAAAG3′
273 bp [9]
blaTEM TEM fw
TEM rev
5′CGCCGCATACACTATTCTCAGAATGA3′
5′ACGCTCACCCGCTCCAGATTTAT3′
445 bp [9]
blaCTX-M CTX-M fw
CTX-M rev
5′ATGTGCAGYACCAGTAARGTKATGGC3′
5′TGGGTRAARTARGTSACCAGAAYCAGCGG3′
593 bp [9]
blaOXA OXA fw
OXA rev
5′ACACAATACATATCAACTTCGC3′
5′AGTGTGTTTAGAATGGTGATC3′
813 bp [9]
aac(6’) aac(6’)-Ia
aac(6’)-Ib
5′TAATTGCTGCATTCCGC3′
5′TGTGACGGAATCGTTGC3′
654 bp [11]
5´CS
3´CS
5′GGCATCCAAGCAGCAAG3′
5′AAGCAGACTTGACCTGA3′
Variable
Variable
[11]
[11]
IntI1-F
IntI1-R
5′GGTCAAGGATCTGGATTTCG3′
5′ACATGCGTGTAAATCATCGTC3′
Variable
Variable
[12]
sulI 5′TGAAGGTTCGACAGCAC3′ Variable [11]
parC parC-up
parC-dn
5′CTGAATGCCAGCGCCAAATT3′
5′TGCGGTGGAATATCGGTCGC3′
319 pb [5]
gyrA gyrA-up
gyrA-dn
5′CGCGTACTATACGCCATGAACGTA3′
5′ACCGTTGATCACTTCGGTCAGG3′
589 pb [5]
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newly admitted patients with clonally related K. pneumoniae 
infection over the study period.  
Antibiotic susceptibility, molecular typing, 
and virulence profile. The isolates showed resistance to 
aminopenicillins, ureidopenicillins, amoxicillin/clavulanic acid, 
and piperacillin/tazobactam, and diminished susceptibility to 
cefepime (MIC range 2–4 µg/ml). They also showed resistance 
to tobramycin, amikacin, and ciprofloxacin (Table 2).
A common PFGE pattern with five different subtypes was 
observed in all K. pneumoniae strains analyzed. This pattern 
was different from those determined in other MDR and non-
MDR K. pneumoniae strains isolated in the same period (Fig. 
3) and was associated with ST14, as confirmed by MLST of 
seven representative strains (allelic profile: gapA 1, infB 6, 
mdh 1, pgi 1, phoE 1, rpoB 1, and tonB 1). This ST is the 
founder of clonal complex 14 (CC14), originally described 
as nosocomial, which has been detected in many countries 
[8]. The CC14/K2 clone is associated with reduced lethality 
in mice, most probably because of the absence of virulence 
determinants [6].  
CC14/K2 strains have been implicated in nosocomial 
outbreaks related to the global spread of antibiotic 
resistance [8]. For instance, the Hungarian epidemic clone 
producing CTX-M-15 belongs to CC14, as does an epidemic 
carbapenemase-producing clone isolated in various facilities 
in the Midwestern United States [10]. These epidemic clones, 
in analogy to methicillin-resistant Staphylococcus aureus 
(MRSA) USA300, have been called the “new MRSAs” [7]. 
However, our results highlight the need for surveillance of 
all MDR K. pneumoniae strains, not only those that produce 
carbapenemase or ESBL.
Characterization of resistance mechanisms. All 
strains were PCR-positive for the blaOXA gene, identified as 
blaOXA-1 after sequencing. On isoelectric focusing, the OXA-1 
betalactamase produced a band with a pI of 7.3. This enzyme 
is widely disseminated in Enterobacteriaceae and is a common 
cause of amoxicillin/clavulanic acid resistance, especially 
in E. coli and Salmonella enterica [12,15]. OXA-1 has also 
been associated with diminished susceptibility to cefepime 
in E. coli and Pseudomonas aeruginosa [2,4]. The transfer 
of this betalactamase by conjugation in E. coli J53-2 yielded 
transconjugants that also exhibited the MDR pattern, with 
the exception of ciprofloxacin MIC, in which resistance was 
diminished in the recipient strain (Table 2). PCR followed by 
sequencing confirmed the presence of the aac(6’)Ib-cr gene in 
both MDR K. pneumoniae strains and their transconjugants. 
The resistance to tobramycin and amikacin was due to aac(6’)Ib, 
encoding an aminoglycoside-modifying enzyme [14]. A new 
variant of this enzyme, encoded by aac(6’)Ib-cr, has been 
recently shown to modify quinolones, thus conferring a low 
level of resistance [4]. QRDR sequencing of GyrA and ParC 
identified a S83F substitution in GyrA [7]. The presence of a 
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Fig. 2. Temporal distribution of newly admitted patients infected with Klebsiella pneumoniae. Striped bars 
represent patients with ICU-acquired K. pneumoniae, and black bars those patients with non-ICU-acquired 
K. pneumoniae.
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GyrA mutation in the strain described here supports the role of 
the enzyme encoded by aac(6´)-Ib-cr in achieving clinically 
relevant resistance levels to quinolones, by selection of 
mutations in QRDR (Table 1) [4]. Since blaOXA-1 is usually 
integron-located, specific amplifications of antibiotic resistance 
genes and integron-specific primers were performed (Table 3). 
These amplifications suggested the presence of a class I integron 
whose variable region contained two resistance genes: aac(6´)
Ib-cr in the first part of the cassette and blaOXA-1 in the second.  
Nosocomial outbreaks due to MDR enterobacteria have 
become a serious problem worldwide, especially given the 
spread of ESBL- or carbapenemase-producing strains [3,16]. 
The OXA-1 betalactamase is widespread among enterobacteria 
and it has been described in isolates from hospitalized 
patients, from patients with community-acquired infections, 
and from sewage. The widespread distribution of the blaOXA-1 
gene is associated with integrons that frequently carry other 
determinants, such as aac(6´)Ib, ESBLs of the CTX-M family, 
and carbapenemases. Moreover, class I integrons harboring 
Table 2. Minimal inhibitory concentration to several antimicrobials of Klebsiella 
pneumoniae strain and its transconjugants
K. pneumoniae strain 8260 K. pneumoniae strain 8260 TC1
Antimicrobial MIC (µg/ml) MIC (µg/ml)
Ampicillin ≥ 32 ≥ 32
Piperacillin ≥ 128 ≥ 128
Ticarcillin ≥ 128 ≥ 128
Amox/
clavulanic ≥ 32/16 ≥ 32/16
Piper/
tazobactam 32 32
Cefuroxime 16 16
Cefotaxime ≤ 2 ≤ 2
Ceftacidime ≤ 1 ≤ 1
Cefepime 2 2
Aztreonam ≤ 1 ≤ 1
Imipenem ≤ 2 ≤ 2
Gentamicin ≤ 4 ≤ 4
Tobramycin ≥ 16 ≥ 16
Amikacin 32 32
Cotrimoxazole ≥ 4/76 ≥ 4/76
Ciprofloxacin 2 0.5
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Fig. 3. PFGE patterns of OXA-1-producing Klebsiella pneumoniae isolates 
after restriction with XbaI. Asterisks (*) indicate contemporary non-clonally 
related K. pneumoniae strains. m: molecular weight marker.
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blaOXA-1-aac(6’)Ib-cr in the variable region are frequently 
described in MDR E. coli and Salmonella enteritidis isolates 
[4,5]. Klebsiella pneumoniae strains of this CC14 have been 
detected among ESBL-producing isolates in Spain; however, 
to the best of our knowledge, ours is the first report of clustered 
infections caused by a non-ESBL-producing K. pneumoniae 
strain harboring blaOXA-1 and aac(6’)Ib-cr. Moreover, the 
strain belonged to ST14 and was detected in a hospital setting 
in Spain [15]. In our studies of other non-MDR non-ESBL-
producing K. pneumoniae strains we noted the high variability 
of these strains, a product of their multiclonality. In addition, 
the MDR strain belonged to ST14, which has been detected in 
European countries and in Tanzania, and Argentina [13,15,17]. 
The detection of these MDR strains in the community is a 
matter of concern because, in the clinical setting, the prolonged 
hospitalization of a colonized or infected patient in a high risk 
unit such as the ICU may allow their spread. These strains are 
not resistant to the majority of betalactam antibiotics used in 
clinical practice, and the problem is not as widespread as in 
the case of ESBL; however, since this multiresistance pattern 
is integron-located, new resistance determinants could be 
incorporated that threaten the effectiveness of the therapeutic 
options currently in use. 
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